Vitamin D Supplementation in Diabetic Nephropathy
NCT01476501 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2022-08-31
Summary
Diabetes is a life-long disease that is getting more common in Canada. One of the most common problems in people with kidney disease is diabetes and low bone mineral density (BMD). This can lead to a higher chance for broken bones, infection and life-long health problems. The most common reason for having low BMD is not getting enough vitamin D (Vit D) in your diet and not having enough sunlight. This is very common in Canada (especially in northern Alberta) because winter is very long. Most people also don't eat or drink enough foods that are high in Vit D (like milk) and so they don't have enough Vit D in their body to make healthy bones. This can mean the only way to get enough Vit D in your body for your bones when you have kidney disease is to take some extra vitamin D in a pill. Most people are not aware that they have poor bone health until they break a bone. Broken bones can really hurt and can prevent a person from being able to walk and take care of themselves. Right now, we are not sure exactly how much Vit D people with diabetes and kidney disease need to take to prevent them from having low BMD or how often they need to take it. Our plan is to study the effect of two ways to take Vit D pills (every day or once a month) on overall Vit D status and on bone health in adult patients with diabetes and chronic kidney disease and see how this influences their quality of life.
Hypotheses:
1. Vitamin D supplementation (2,000 IU/day and 40,000 IU/month) for six months will result in significantly improved overall vitamin D status and improved markers of bone health in adult patients with diabetic nephropathy.
2. Monthly dosing of vitamin D (40,000 IU/month) over six months will result in improved patient adherence and satisfaction with vitamin D supplementation when compared to daily dosing of vitamin D (2000 IU/D). This will improve vitamin D status and bone health parameters, which will result in an increased quality of life and sense of well-being.
Conditions
- Sub-optimal Vitamin D Status
- Bone Disease
- Diabetic Nephropathy
Interventions
- DRUG
-
Vitamin D3
Randomized into 1 of 2 oral vitamin D3 softgel capsule supplementation strategies: 1) 2,000 IU/day (2 x 1,000IU/capsule each day) or 2) 40,000 IU/month (4 x 10,000IU/capsule last day of each month), for 6 months each.
Sponsors & Collaborators
-
University of Alberta
lead OTHER
Principal Investigators
-
Diana R Mager, PhD RD · University of Alberta
-
Peter A Senior, MBBS PhD · University of Alberta
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2014-12-31
- Completion
- 2015-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Vitamin D Metabolism in Chronic Kidney Disease Patients
NCT01528176 ·Status: UNKNOWN ·Phase: NA
-
Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease
NCT00552409 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Oral Cholecalciferol (Vitamin D3) on Bone Health, Neuromuscular Function, and Quality of Life in Adults With Chronic Kidney Disease
NCT00511225 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients
NCT01457001 ·Status: TERMINATED ·Phase: PHASE3
-
Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects
NCT00427037 ·Status: COMPLETED ·Phase: NA
-
Vitamin D and Chronic Renal Insufficiency
NCT00968877 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-dependent Effects of Vitamin D on Bone Health
NCT01900860 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Vitamin D to Treat Contrast-induced Nephropathy
NCT02489240 ·Status: UNKNOWN ·Phase: NA
-
Impact of Vitamin D Repletion in Hemodialysis Patients
NCT01175798 ·Status: COMPLETED ·Phase: NA
-
A Study of 25-hydroxy Vitamin d Levels in Non-itching Hemodialysis Patients
NCT01548716 ·Status: COMPLETED
-
The Effect of Vitamin D on Urinary Calcium Excretion in Kidney Stone Formers With High Urinary Calcium
NCT00948740 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management
NCT06571344 ·Status: RECRUITING
-
Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease
NCT01012414 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Vitamin D3 Supplementation in Patients With Chronic Kidney Disease
NCT00893451 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Supplementation in Kidney Disease
NCT01229878 ·Status: COMPLETED ·Phase: NA
-
Cholecalciferol Supplementation Effect on Parathyroid Hormone in Hemodialysis Patients
NCT03648528 ·Status: COMPLETED ·Phase: PHASE4
-
Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation
NCT03576716 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Vitamin D on Diabetic Kidney Disease in African Americans
NCT01214356 ·Status: COMPLETED ·Phase: NA
-
Importance of Dosing Regimen for the Effect of Vitamin D Supplementation
NCT03272126 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamin D Supplementation in CKD - Vascular Function, Structure and Immune Regulation
NCT04380467 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Administration in the Nursing Home
NCT00204919 ·Status: COMPLETED ·Phase: NA
-
The Effect of Vitamin D Repletion on Kidney Stone Risk
NCT02752841 ·Status: TERMINATED ·Phase: NA
-
Vitamin D Supplementation in Older Adults With Urinary Incontinence
NCT01971801 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Supplementation and Cardiac Hypertrophy in Chronic Kidney Disease (CKD)
NCT01323712 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.
NCT02238418 ·Status: COMPLETED ·Phase: PHASE4